A New Audio Interview with The CEO of Cyplasin,
Garth Likes, is Now at SmallCapVoice.com
April 26, 2010 08:03 AM Eastern Daylight Time
AUSTIN, Texas--(EON: Enhanced Online News)--SmallCapVoice.com, Inc. announced today that a new audio
interview with Cyplasin Biomedical (Cyplasin), a publically-traded specialty pharmaceutical company with
headquarters in Edmonton, Alberta, Canada (OTCBB:CPBM.OB), is now available. The interview can be heard at
SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to
help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com
utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients' financial news
releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions
about the stocks they are interested in. Tools like stock charts, stock alerts, and investor fact sheets can assist with
investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and
their services, please visit http://www.smallcapvoice.com/services.html.
About Cyplasin Biomedical
Cyplasin Biomedical is a public biopharmaceutical company focused on the commercialization of life-saving products
targeted for sale in the multi-billion dollar global hepatitis C market.
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act.
The statements reflect the Company's current views with respect to future events that involve risks and uncertainties.
Among others, these risks include the failure to meet schedule or performance requirements of the Company's
contracts, the Company's liquidity position, the Company's ability to obtain new contracts, the emergence of
competitors with greater financial resources,